These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 24592552)
21. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? D'Haens GR; Panaccione R; Higgins PD; Vermeire S; Gassull M; Chowers Y; Hanauer SB; Herfarth H; Hommes DW; Kamm M; Löfberg R; Quary A; Sands B; Sood A; Watermeyer G; Lashner B; Lémann M; Plevy S; Reinisch W; Schreiber S; Siegel C; Targan S; Watanabe M; Feagan B; Sandborn WJ; Colombel JF; Travis S Am J Gastroenterol; 2011 Feb; 106(2):199-212; quiz 213. PubMed ID: 21045814 [TBL] [Abstract][Full Text] [Related]
22. A review of infliximab use in ulcerative colitis. Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261 [TBL] [Abstract][Full Text] [Related]
23. Crohn's disease successfully treated with infliximab in a patient receiving hemodialysis: case report and review of the literature. Chiba M; Tsuda S; Tsuji T; Nakane K; Komatsu M; Miura Y; Ishida T; Shibahara T; Nishimoto T Medicine (Baltimore); 2014 Aug; 93(7):e54. PubMed ID: 25101989 [TBL] [Abstract][Full Text] [Related]
24. Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis. Swaminath A; Lichtiger S Inflamm Bowel Dis; 2008 Feb; 14(2):213-6. PubMed ID: 18022870 [TBL] [Abstract][Full Text] [Related]
26. Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy. Katoh N; Kubota M; Shimojima Y; Ishii W; Matsuda M; Akamatsu T; Ikeda S Intern Med; 2010; 49(2):179-82. PubMed ID: 20075586 [TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus complicated by Crohn's disease: a case report and literature review. Yamashita H; Ueda Y; Kawaguchi H; Suzuki A; Takahashi Y; Kaneko H; Kano T; Mimori A BMC Gastroenterol; 2012 Dec; 12():174. PubMed ID: 23216789 [TBL] [Abstract][Full Text] [Related]
29. Abnormal bone metabolism in Crohn's disease. Wu T; Song HY; Ji G Front Biosci (Landmark Ed); 2012 Jun; 17(7):2675-83. PubMed ID: 22652805 [TBL] [Abstract][Full Text] [Related]
30. Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions. Desai J; Elnaggar M; Hanfy AA; Doshi R Clin Exp Gastroenterol; 2020; 13():203-210. PubMed ID: 32547151 [TBL] [Abstract][Full Text] [Related]
31. Is really megacolon a contraindication to infliximab in Crohn's disease? Sinagra E; Orlando A; Renna S; Criscuoli V; La Seta F; Olivo M; Ciofalo M; Cottone M Acta Gastroenterol Belg; 2013 Dec; 76(4):442-4. PubMed ID: 24592552 [TBL] [Abstract][Full Text] [Related]
32. Use of infliximab and anti-infliximab antibody measurements to evaluate and optimize efficacy and safety of infliximab maintenance therapy in Crohn's disease. Steenholdt C Dan Med J; 2013 Apr; 60(4):B4616. PubMed ID: 23651723 [TBL] [Abstract][Full Text] [Related]
33. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]
35. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease. Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628 [TBL] [Abstract][Full Text] [Related]
36. Buccal localization of Crohn's disease with long-term infliximab therapy: a case report. Ciacci C; Bucci C; Zingone F; Iovino P; Amato M J Med Case Rep; 2014 Nov; 8():397. PubMed ID: 25433368 [TBL] [Abstract][Full Text] [Related]